TP53 and lung cancer: More recently a report on 70 multifocal lung cancers from 30 individuals suggested, on the basis of both LOH and TP53 mutational analysis, that in 77% of individuals the lesions were clonally related, and concluded that the mechanism underlying their monoclonal origin was local and intrapulmonary metastasis from established cancers 12.